M. Shimamura
Medical R&D Center
The Tokyo Metropolitan Institute of Medical Science
Japan
Name/email consistency: high
- A novel hypoxia-dependent 2-nitroimidazole KIN-841 inhibits tumour-specific angiogenesis by blocking production of angiogenic factors. Shimamura, M., Nagasawa, H., Ashino, H., Yamamoto, Y., Hazato, T., Uto, Y., Hori, H., Inayama, S. Br. J. Cancer (2003)









